Amylyx Stock Analysis

The current indifference towards the small price fluctuations of Amylyx Pharmaceuticals could raise concerns from investors as the firm it trading at a share price of 0.0 on very low momentum in volume. The company directors and management did not add any value to Amylyx Pharmaceuticals investors in December. However, most investors can still diversify their portfolios with Amylyx Pharmaceuticals to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to investors with longer-term investment horizons.
Check out Trending Equities.

Amylyx Stock Analysis 

 
Refresh
The Amylyx Pharmaceuticals stock analysis report makes it easy to digest most publicly released information about Amylyx Pharmaceuticals and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Amylyx Stock analysis module also helps to analyze the Amylyx Pharmaceuticals price relationship with some important fundamental indicators such as market cap and management efficiency.

Amylyx Stock Analysis Notes

The company next dividend is scheduled to be issued on the 28th of March 1970. The investment seeks to provide a high level of current income as its primary investment objective and to provide returns from energy master limited partnerships with a view toward reduced volatility as its secondary investment objective. Amplify YieldShares is traded on BATS Exchange in USA. For more info on Amylyx Pharmaceuticals please contact the company at 855-267-3837.

Amylyx Pharmaceuticals Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Amylyx Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Amylyx Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Amylyx Pharmaceuticals is not yet fully synchronised with the market data
Amylyx Pharmaceuticals has some characteristics of a very speculative penny stock
Amylyx Pharmaceuticals has a very weak financial position based on the latest SEC disclosures

Amylyx Pharmaceuticals SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Amylyx Pharmaceuticals prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Amylyx Pharmaceuticals investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Amylyx Pharmaceuticals specific information freely available to individual and institutional investors to make a timely investment decision.
11th of January 2022
Financial Statements and Exhibits. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year
View

Amylyx Profitablity

Amylyx Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Amylyx Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Amylyx Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Amylyx Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Amylyx Pharmaceuticals' profitability requires more research than a typical breakdown of Amylyx Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(4.39) (4.74) 
Return on Average Equity 0.83  0.83 
Return on Invested Capital 13.38  13.30 
Return on Sales(55.37) (59.74) 

Management Efficiency

Return on Average Assets is likely to drop to -4.74 in 2022. Return on Invested Capital is likely to drop to 13.30 in 2022. Assets Non Current is likely to rise to about 577 K in 2022, whereas Total Assets are likely to drop slightly above 13.6 M in 2022. Amylyx Pharmaceuticals management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for 2022
Book Value per Share(9.88) (10.66) 
Tangible Assets Book Value per Share 2.67  2.23 
Tangible Asset Value16.2 M13.6 M

Amylyx Pharmaceuticals Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Amylyx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Amylyx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Amylyx Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Amylyx Pharmaceuticals Technical and Predictive Indicators

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Amylyx Pharmaceuticals to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module
Check out Trending Equities. Note that the Amylyx Pharmaceuticals information on this page should be used as a complementary analysis to other Amylyx Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Tools for Amylyx Stock

When running Amylyx Pharmaceuticals price analysis, check to measure Amylyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amylyx Pharmaceuticals is operating at the current time. Most of Amylyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amylyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amylyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amylyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go